VAM
GILD icon

Verity Asset Management’s Gilead Sciences GILD Stock Holding History

Verity Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.28M Sell
10,134
-298
-3% -$39.3K 0.48% 63
2026
Q1 		$1.45M Buy
10,432
+75
+0.7% +$10.5K 0.61% 54
2025
Q4 		$1.27M Sell
10,357
-10,237
-50% -$1.24M 0.55% 54
2025
Q3 		$2.29M Buy
20,594
+8,800
+75% +$1M 0.75% 32
2025
Q2 		$1.31M Sell
11,794
-12,446
-51% -$1.32M 0.62% 44
2025
Q1 		$2.72M Buy
24,240
+12,383
+104% +$1.28M 1.11% 18
2024
Q4 		$1.1M Buy
11,857
+997
+9% +$89.8K 0.62% 41
2024
Q3 		$911K Buy
10,860
+2,066
+23% +$158K 0.34% 80
2024
Q2 		$603K Buy
8,794
+123
+1% +$8.21K 0.24% 92
2024
Q1 		$635K Sell
8,671
-60
-0.7% -$4.61K 0.35% 73
2023
Q4 		$707K Buy
8,731
+168
+2% +$13.1K 0.45% 58
2023
Q3 		$642K Buy
8,563
+948
+12% +$72.9K 0.47% 61
2023
Q2 		$587K Sell
7,615
-109
-1% -$8.69K 0.44% 70
2023
Q1 		$641K Sell
7,724
-287
-4% -$23.8K 0.38% 79
2022
Q4 		$688K Sell
8,011
-4,384
-35% -$347K 0.59% 57
2022
Q3 		$765K Buy
+12,395
New +$782K 0.79% 41
2022
Q1 		$673K Buy
11,316
+3,904
+53% +$250K 0.43% 73
2021
Q4 		$538K Sell
7,412
-7,743
-51% -$533K 0.32% 96
2021
Q3 		$1.06M Buy
15,155
+247
+2% +$17.4K 0.69% 32
2021
Q2 		$1.03M Buy
14,908
+4,254
+40% +$284K 0.56% 39
2021
Q1 		$689K Buy
10,654
+2,208
+26% +$142K 0.41% 72
2020
Q4 		$492K Sell
8,446
-1,044
-11% -$63K 0.34% 80
2020
Q3 		$600K Buy
9,490
+2,553
+37% +$177K 0.46% 50
2020
Q2 		$500K Buy
6,937
+3,195
+85% +$245K 0.46% 55
2020
Q1 		$280K Buy
+3,742
New +$259K 0.35% 89
2015
Q4 		– Sell
-2,614
Closed -$257K – 82
2015
Q3 		$257K Buy
+2,614
New +$290K 0.26% 65

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Verity Asset Management's GILD Position: Q2 2026 in Review

Verity Asset Management reduced its Gilead Sciences (GILD) stake by 2.9% in Q2 2026, selling an estimated $39.3K and leaving 10,134 shares worth $1.28M. The position accounts for 0.48% of the portfolio, ranked #63.

Verity Asset Management first reported a position in GILD in Q3 2015 and has held it in 26 quarters since. The position peaked at $2.72M in Q1 2025. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Verity Asset Management held 10,134 shares of Gilead Sciences worth $1.28M as of Q2 2026.
  • Verity Asset Management sold 298 Gilead Sciences shares in Q2 2026, an estimated $39.3K.
  • Gilead Sciences made up 0.48% of Verity Asset Management's portfolio in Q2 2026, its #63 holding.
  • Verity Asset Management first reported a position in Gilead Sciences in Q3 2015 and has held it in 26 quarters since.
  • Verity Asset Management's Gilead Sciences position peaked at $2.72M in Q1 2025.
  • 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Verity Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.